Primo Medical Group and Management Acquire Arthrosurface from Anika Therapeutics
October 31, 2024
Primo Medical Group, together with former Arthrosurface executives and a newly formed parent company Phoenix Brio, acquired Arthrosurface, a maker of joint restoration and preservation implants, from Anika Therapeutics. The deal returns Arthrosurface to independent ownership with Phoenix Brio as the parent and operations based in West Bridgewater, Massachusetts.
- Buyers
- Primo Medical Group, Phoenix Brio, Arthrosurface executive management
- Targets
- Arthrosurface
- Sellers
- Anika Therapeutics
- Industry
- Medical Devices
- Location
- Massachusetts, United States
- Transaction Type
- Divestiture
Explore More
Related Acquisitions
-
Inflexion Acquires Primed Group
July 17, 2026
Healthcare Services
Inflexion has agreed to acquire Primed Group, a German manufacturer and distributor of single-use medical consumables and operator of a major medical sterilization platform. The deal is being purchased from Paragon Partners, with financial terms not disclosed.
-
Sobi Completes Acquisition of Arthrosi Therapeutics for Up to $1.5 Billion
February 9, 2026
Pharmaceuticals
Swedish Orphan Biovitrum AB (Sobi) has completed its acquisition of Arthrosi Therapeutics, purchasing all outstanding shares of Arthrosi’s common stock and common stock equivalents. The deal adds pozdeutinurad (AR882), a once-daily oral URAT1 inhibitor in two fully enrolled Phase 3 studies for progressive and tophaceous gout.
-
SyAqua (Ocean 14 Capital) Acquires Primo Broodstock
July 16, 2024
Agriculture
Singapore-based shrimp genetics company SyAqua, which is majority-owned by Luxembourg-headquartered private equity firm Ocean 14 Capital, has acquired Mims, Florida–based Primo Broodstock. The acquisition expands SyAqua’s U.S. broodstock production capacity and genetic resources, enhancing strain security and enabling increased supply to major shrimp-producing markets.
-
Primus Capital Invests in Prendio and BioProcure
October 18, 2023
Cloud & SaaS
Primus Capital has made a growth equity investment in Prendio and sister company BioProcure to support organic growth, expansion into additional life-sciences markets, and continued product and service innovation. The investment will back Prendio's cloud-based eProcurement SaaS and BioProcure's procure-to-pay support services for biotech customers; Aeris Partners served as exclusive financial advisor to the sellers and law firms Latham & Watkins and Goodwin Proctor served as legal advisors.
-
ARCHIMED Acquires WiQo S.p.A.
March 9, 2023
Medical Devices
ARCHIMED, a Europe-based healthcare private equity firm, has acquired WiQo, an Italian developer and manufacturer of the PRX‑T33 topical biostimulator used in aesthetic medicine. Founders (Dr. Rossana Castellana and family) retained a 25% stake and Castellana will stay on to lead R&D; the deal was financed with debt provided by Banco BPM and Crédit Agricole Italia and is the fourth investment from ARCHIMED's MED III fund.
-
Oakley Capital Acquires PRIMAVERA and Creates Grupo Primavera with Ekon
June 22, 2021
Software
Oakley Capital Private Equity III has agreed to acquire PRIMAVERA Business Software Solutions, the Portuguese leader in ERP and business management software, from founders José Dionísio and Jorge Batista. The business will be combined with Oakley’s existing portfolio company Ekon and recent bolt-ons to form Grupo Primavera, a leading independent Iberian SME software platform focused on accelerating SaaS adoption.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.